Global portfolio pricing and launch strategy for innovative oncology sequencing tests

Published on August 8, 2025

Simon-Kucher case study: Global portfolio pricing and launch strategy for innovative oncology sequencing tests

Continue reading on website
Other news

Minimal Residual Disease in solid tumors: The next big thing in oncology diagnostics

August 8, 2025
.t-box {background-color: #e1eff5;padding: 1rem;}Minimal Residual Disease (MRD) is redefining oncology diagnostics. This article covers the current landscape, key barriers, and emerging opportunities, and outlines what it will take to drive successful adoption at scale.The modern oncology continuum envisions a seamless flow from prevention and early detection through treatment selection, response

5 new rules of growth for PE-backed insurance brokerages

August 8, 2025
A more capital-efficient, system-driven model is taking hold across the insurance industry. With interest rates still high, PE-backed insurance brokerages are feeling the pressure to grow, but in a way that actually sticks and turns a profit. Traditional tactics like aggressive lead buying and high-cost producer compensation are working but they are losing their effectiveness as acquisition costs